Aptus Capital Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $83.9K | Hold |
3,447
| – | – | ﹤0.01% | 1100 |
|
|
2025
Q1 | $71.6K | Buy |
3,447
+2,960
| +608% | +$61.4K | ﹤0.01% | 1057 |
|
|
2024
Q4 | $11.5K | Sell |
487
-33
| -6% | -$778 | ﹤0.01% | 1261 |
|
|
2024
Q3 | $13.3K | Hold |
520
| – | – | ﹤0.01% | 1073 |
|
|
2024
Q2 | $12.2K | Hold |
520
| – | – | ﹤0.01% | 1010 |
|
|
2024
Q1 | $15K | Sell |
520
-5
| -1% | -$144 | ﹤0.01% | 992 |
|
|
2023
Q4 | $17.2K | Sell |
525
-5,513
| -91% | -$181K | ﹤0.01% | 755 |
|
|
2023
Q3 | $168K | Buy |
6,038
+275
| +5% | +$7.66K | ﹤0.01% | 579 |
|
|
2023
Q2 | $196K | Sell |
5,763
-1,175
| -17% | -$40.1K | ﹤0.01% | 476 |
|
|
2023
Q1 | $209K | Buy |
6,938
+4,629
| +200% | +$139K | 0.01% | 461 |
|
|
2022
Q4 | $65.2K | Buy |
2,309
+1,443
| +167% | +$40.7K | ﹤0.01% | 570 |
|
|
2022
Q3 | $28K | Buy |
866
+684
| +376% | +$22.1K | ﹤0.01% | 588 |
|
|
2022
Q2 | $6K | Hold |
182
| – | – | ﹤0.01% | 589 |
|
|
2022
Q1 | $8K | Sell |
182
-299
| -62% | -$13.1K | ﹤0.01% | 608 |
|
|
2021
Q4 | $29K | Sell |
481
-55
| -10% | -$3.32K | ﹤0.01% | 441 |
|
|
2021
Q3 | $40K | Sell |
536
-1,512
| -74% | -$113K | ﹤0.01% | 406 |
|
|
2021
Q2 | $190K | Buy |
2,048
+195
| +11% | +$18.1K | 0.01% | 342 |
|
|
2021
Q1 | $165K | Buy |
1,853
+591
| +47% | +$52.6K | 0.01% | 326 |
|
|
2020
Q4 | $117K | Buy |
+1,262
| New | +$117K | 0.01% | 312 |
|